115 related articles for article (PubMed ID: 15675597)
1. [Endocrine tumor].
Sasano H
Gan To Kagaku Ryoho; 2005 Jan; 32(1):121-4. PubMed ID: 15675597
[TBL] [Abstract][Full Text] [Related]
2. Practical markers used in the diagnosis of endocrine tumors.
Erickson LA; Lloyd RV
Adv Anat Pathol; 2004 Jul; 11(4):175-89. PubMed ID: 15220821
[TBL] [Abstract][Full Text] [Related]
3. Histopathological variables and biomarkers enhancer of zeste homologue 2, Ki-67 and minichromosome maintenance protein 7 as prognosticators in primarily endocrine-treated prostate cancer.
Tolonen TT; Tammela TL; Kujala PM; Tuominen VJ; Isola JJ; Visakorpi T
BJU Int; 2011 Nov; 108(9):1430-8. PubMed ID: 21592298
[TBL] [Abstract][Full Text] [Related]
4. Criteria for malignancy in gastrointestinal endocrine tumors.
Bordi C; D'Adda T; Azzoni C; Pizzi S; Bottarelli L; Mormandi F; Antonetti T; Luong TV; Rindi G
Endocr Pathol; 2006; 17(2):119-29. PubMed ID: 17159244
[TBL] [Abstract][Full Text] [Related]
5. High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma.
Vékony H; Raaphorst FM; Otte AP; van Lohuizen M; Leemans CR; van der Waal I; Bloemena E
J Clin Pathol; 2008 Jun; 61(6):744-9. PubMed ID: 18326020
[TBL] [Abstract][Full Text] [Related]
6. Subtyping does matter in pituitary adenomas.
Kleinschmidt-DeMasters BK
Acta Neuropathol; 2006 Jan; 111(1):84-5. PubMed ID: 16328517
[No Abstract] [Full Text] [Related]
7. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
[TBL] [Abstract][Full Text] [Related]
8. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.
Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A
Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
Vezzosi D; Bouisson M; Escourrou G; Laurell H; Selves J; Seguin P; Pradayrol L; Caron P; Buscail L
Clin Endocrinol (Oxf); 2006 Jan; 64(1):63-7. PubMed ID: 16402930
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of P450scc gene expression in neural and steroidogenic cells: implications for regulation of neurosteroidogenesis.
Zhang P; Rodriguez H; Mellon SH
Mol Endocrinol; 1995 Nov; 9(11):1571-82. PubMed ID: 8584034
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer.
Mattioli E; Vogiatzi P; Sun A; Abbadessa G; Angeloni G; D'Ugo D; Trani D; Gaughan JP; Vecchio FM; Cevenini G; Persiani R; Giordano A; Claudio PP
J Cell Physiol; 2007 Jan; 210(1):183-91. PubMed ID: 16998811
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers.
Llombart B; Monteagudo C; López-Guerrero JA; Carda C; Jorda E; Sanmartín O; Almenar S; Molina I; Martín JM; Llombart-Bosch A
Histopathology; 2005 Jun; 46(6):622-34. PubMed ID: 15910593
[TBL] [Abstract][Full Text] [Related]
13. Incidentally discovered tumors of the endocrine glands.
Vardanian AJ; Hines OJ; Farrell JJ; Yeh MW
Future Oncol; 2007 Aug; 3(4):463-74. PubMed ID: 17661721
[TBL] [Abstract][Full Text] [Related]
14. CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors.
La Rosa S; Rigoli E; Uccella S; Chiaravalli AM; Capella C
Virchows Arch; 2004 Sep; 445(3):248-54. PubMed ID: 15517368
[TBL] [Abstract][Full Text] [Related]
15. INI1 (BAF 47) immunohistochemistry is an essential diagnostic tool for children with hepatic tumors and low alpha fetoprotein.
Al Nassan A; Sughayer M; Matalka I; Ghandour K; Masarweh M; Zimmermann A; Sultan I
J Pediatr Hematol Oncol; 2010 Mar; 32(2):e79-81. PubMed ID: 20048688
[TBL] [Abstract][Full Text] [Related]
16. Ad4BP in the human adrenal cortex and its disorders.
Sasano H; Shizawa S; Suzuki T; Takayama K; Fukaya T; Morohashi K; Nagura H
J Clin Endocrinol Metab; 1995 Aug; 80(8):2378-80. PubMed ID: 7629233
[TBL] [Abstract][Full Text] [Related]
17. Classic and recent special stains used in differential diagnosis of endocrine tumors.
Bussolati G; Volante M; Papotti M
Endocr Pathol; 2001; 12(4):379-87. PubMed ID: 11914471
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of nuclear transcription factors, DAX-1 and COUP-TF II, in the normal human ovary: correlation with adrenal 4 binding protein/steroidogenic factor-1 immunolocalization during the menstrual cycle.
Sato Y; Suzuki T; Hidaka K; Sato H; Ito K; Ito S; Sasano H
J Clin Endocrinol Metab; 2003 Jul; 88(7):3415-20. PubMed ID: 12843196
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of the neural development transcription factors (TTF1, ASCL1 and BRN2) in neuroendocrine prostate tumours.
Rodríguez-Zarco E; Vallejo-Benítez A; Umbría-Jiménez S; Pereira-Gallardo S; Pabón-Carrasco S; Azueta A; González-Cámpora R; Espinal PS; García-Escudero A
Actas Urol Esp; 2017 Oct; 41(8):529-534. PubMed ID: 28285791
[TBL] [Abstract][Full Text] [Related]
20. Adrenocorticotropin-dependent changes in SF-1/DAX-1 ratio influence steroidogenic genes expression in a novel model of glucocorticoid-producing adrenocortical cell lines derived from targeted tumorigenesis.
Ragazzon B; Lefrançois-Martinez AM; Val P; Sahut-Barnola I; Tournaire C; Chambon C; Gachancard-Bouya JL; Begue RJ; Veyssière G; Martinez A
Endocrinology; 2006 Apr; 147(4):1805-18. PubMed ID: 16439455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
